Log in to save to my catalogue

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8610eb7df3964ea8bea95822a4030a13

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis

About this item

Full title

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-08, Vol.14 (1), p.5077-5077, Article 5077

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Aberrant coagulation and thrombosis are associated with severe COVID-19 post-SARS-CoV-2 infection, yet the underlying mechanism remains obscure. Here we show that serum levels of SARS-CoV-2 envelope (E) protein are associated with coagulation disorders of COVID-19 patients, and intravenous administration of the E protein is able to potentiate throm...

Alternative Titles

Full title

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8610eb7df3964ea8bea95822a4030a13

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8610eb7df3964ea8bea95822a4030a13

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-40824-7

How to access this item